JP2010047612A5 - - Google Patents

Download PDF

Info

Publication number
JP2010047612A5
JP2010047612A5 JP2009272270A JP2009272270A JP2010047612A5 JP 2010047612 A5 JP2010047612 A5 JP 2010047612A5 JP 2009272270 A JP2009272270 A JP 2009272270A JP 2009272270 A JP2009272270 A JP 2009272270A JP 2010047612 A5 JP2010047612 A5 JP 2010047612A5
Authority
JP
Japan
Prior art keywords
nateglinide
preparation according
tablet
preparation
per tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009272270A
Other languages
English (en)
Japanese (ja)
Other versions
JP5282722B2 (ja
JP2010047612A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009272270A priority Critical patent/JP5282722B2/ja
Priority claimed from JP2009272270A external-priority patent/JP5282722B2/ja
Publication of JP2010047612A publication Critical patent/JP2010047612A/ja
Publication of JP2010047612A5 publication Critical patent/JP2010047612A5/ja
Application granted granted Critical
Publication of JP5282722B2 publication Critical patent/JP5282722B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009272270A 2003-08-08 2009-11-30 ナテグリニド含有製剤 Expired - Fee Related JP5282722B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009272270A JP5282722B2 (ja) 2003-08-08 2009-11-30 ナテグリニド含有製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290464 2003-08-08
JP2003290464 2003-08-08
JP2009272270A JP5282722B2 (ja) 2003-08-08 2009-11-30 ナテグリニド含有製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005513036A Division JP4505859B2 (ja) 2003-08-08 2004-08-09 ナテグリニド含有製剤

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011222076A Division JP4947820B2 (ja) 2003-08-08 2011-10-06 ナテグリニド含有製剤
JP2012236421A Division JP5557169B2 (ja) 2003-08-08 2012-10-26 ナテグリニド含有製剤

Publications (3)

Publication Number Publication Date
JP2010047612A JP2010047612A (ja) 2010-03-04
JP2010047612A5 true JP2010047612A5 (enExample) 2012-01-05
JP5282722B2 JP5282722B2 (ja) 2013-09-04

Family

ID=34131587

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2005513036A Expired - Lifetime JP4505859B2 (ja) 2003-08-08 2004-08-09 ナテグリニド含有製剤
JP2008265459A Expired - Fee Related JP4995798B2 (ja) 2003-08-08 2008-10-14 ナテグリニド含有製剤
JP2009272270A Expired - Fee Related JP5282722B2 (ja) 2003-08-08 2009-11-30 ナテグリニド含有製剤
JP2011222076A Expired - Lifetime JP4947820B2 (ja) 2003-08-08 2011-10-06 ナテグリニド含有製剤
JP2012236421A Expired - Lifetime JP5557169B2 (ja) 2003-08-08 2012-10-26 ナテグリニド含有製剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2005513036A Expired - Lifetime JP4505859B2 (ja) 2003-08-08 2004-08-09 ナテグリニド含有製剤
JP2008265459A Expired - Fee Related JP4995798B2 (ja) 2003-08-08 2008-10-14 ナテグリニド含有製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011222076A Expired - Lifetime JP4947820B2 (ja) 2003-08-08 2011-10-06 ナテグリニド含有製剤
JP2012236421A Expired - Lifetime JP5557169B2 (ja) 2003-08-08 2012-10-26 ナテグリニド含有製剤

Country Status (4)

Country Link
US (1) US7732492B2 (enExample)
JP (5) JP4505859B2 (enExample)
KR (2) KR100882156B1 (enExample)
WO (1) WO2005013964A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3227424B2 (ja) 1998-02-13 2001-11-12 大日精化工業株式会社 育成効果を有する芝生着色剤組成物
AU2001295999A1 (en) * 2000-10-24 2002-05-06 Ajinomoto Co., Inc. Nateglinide-containing preparations
WO2005013964A1 (ja) 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
CN101420937B (zh) * 2006-04-12 2011-06-22 日本曹达株式会社 缓释性片剂的制造方法
US9790538B2 (en) 2013-03-07 2017-10-17 Apdn (B.V.I.) Inc. Alkaline activation for immobilization of DNA taggants
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
CN101594863B (zh) * 2006-12-07 2011-12-07 第一三共株式会社 具有改进稳定性的涂膜制剂
WO2008072535A1 (ja) 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
US20100004279A1 (en) * 2006-12-07 2010-01-07 Tomoyuki Watanabe Solid medicinal preparation containing mannitol or lactose
WO2008072533A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 固形製剤の製造方法
WO2008136394A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の製造方法及びその製造中間体
TR200801178A2 (tr) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
US8513261B2 (en) * 2009-03-13 2013-08-20 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
CN106963741A (zh) * 2010-03-29 2017-07-21 Ea制药株式会社 含有苯基丙氨酸衍生物的医药制剂
WO2013066278A1 (en) * 2011-11-03 2013-05-10 Mahmut Bilgic A process for production of pharmaceutical formulations comprising nateglinide
EP2809316A1 (en) * 2012-01-31 2014-12-10 Mahmut Bilgic Synergisctic combination comprising a meglitinide derivative and lipoic acid
EP2832350B1 (en) 2012-03-29 2019-07-17 Daicel Corporation Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose
US9297032B2 (en) * 2012-10-10 2016-03-29 Apdn (B.V.I.) Inc. Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings
US9266370B2 (en) 2012-10-10 2016-02-23 Apdn (B.V.I) Inc. DNA marking of previously undistinguished items for traceability
US9963740B2 (en) 2013-03-07 2018-05-08 APDN (B.V.I.), Inc. Method and device for marking articles
CN105555262A (zh) * 2013-09-27 2016-05-04 株式会社大赛璐 含有崩解性颗粒组合物的口腔内崩解片剂
WO2015054188A1 (en) 2013-10-07 2015-04-16 Apdn (B.V.I), Inc. Multimode image and spectral reader
CN106103121B (zh) 2014-03-18 2019-12-06 亚普蒂恩(B.V.I.)公司 用于安全应用的加密光学标记物
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
US10760182B2 (en) 2014-12-16 2020-09-01 Apdn (B.V.I.) Inc. Method and device for marking fibrous materials
CN109070130B (zh) 2016-04-11 2022-03-22 亚普蒂恩（B V I）公司 用于标记纤维素产品的方法
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
WO2018156352A1 (en) 2017-02-21 2018-08-30 Apdn (B.V.I) Inc. Nucleic acid coated submicron particles for authentication

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
JPS5438167B2 (enExample) * 1974-04-27 1979-11-19
JPS5344618A (en) * 1976-10-04 1978-04-21 Takeda Chem Ind Ltd Preparation of tablet
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
JPH0415221A (ja) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd ポリカーボネートの製造法
JPH09208468A (ja) * 1996-02-02 1997-08-12 Dainippon Pharmaceut Co Ltd ｐ−クロロ−Ｎ−（２−モルホリノエチル）ベンズアミドを含有する錠剤
JP3180350B2 (ja) * 1996-02-29 2001-06-25 藤沢薬品工業株式会社 β―ラクタム系抗生物質含有錠剤およびその製造法
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
WO1998000136A1 (en) * 1996-07-01 1998-01-08 Pfizer Inc. Virginiamycin mixture
KR100343062B1 (ko) 1996-11-15 2002-07-02 에가시라 구니오 정제 조성물
JPH10298062A (ja) * 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd 口腔内速溶型錠剤
JP2945001B1 (ja) * 1997-09-10 1999-09-06 大日本製薬株式会社 カーボン１３尿素含有錠
DE69942777D1 (de) * 1998-07-28 2010-10-28 Takeda Pharmaceutical Leicht zerfallende feste Zubereitung
JP2000178184A (ja) * 1998-12-17 2000-06-27 Lion Corp 粒状組成物、錠剤及び粒状組成物の製造方法
JP2000351732A (ja) * 1999-06-07 2000-12-19 Taisho Pharm Ind Ltd 水分散性良好なアシクロビル含有錠剤
UA72922C2 (uk) * 1999-08-03 2005-05-16 Ліллі Айкос Ллк ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
BR0016631A (pt) 1999-12-23 2003-01-07 Novartis Ag Uso de agentes hipoglicêmico para tratar metabolismo de glicose depreciada
ES2248159T3 (es) * 1999-12-28 2006-03-16 Ajinomoto Co., Inc. Preparaciones orales para diabetes.
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
SK18062002A3 (sk) 2000-06-22 2003-07-01 Novartis Ag Pevné orálne farmaceutické kompozície obsahujúce valsartan
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
AU2001288102A1 (en) 2000-09-22 2002-04-02 Takeda Chemical Industries Ltd. Solid preparations
PT1334721E (pt) * 2000-10-24 2009-06-01 Ajinomoto Kk Preparações de fármacos hidrofílicos contendo nateglinida
AU2001295999A1 (en) * 2000-10-24 2002-05-06 Ajinomoto Co., Inc. Nateglinide-containing preparations
JP4370050B2 (ja) * 2000-12-04 2009-11-25 大正製薬株式会社 クラリスロマイシン錠剤およびその製造法
JP2002326925A (ja) * 2001-04-27 2002-11-15 Asahi Breweries Ltd 造粒物および錠剤の製造方法
GB0128378D0 (en) 2001-11-27 2002-01-16 Smithkline Beecham Plc Novel Compounds
JP2003201256A (ja) 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
JP4029926B2 (ja) * 2002-01-25 2008-01-09 サンウエーブ工業株式会社 回転式載置台
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
WO2005013964A1 (ja) 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
CN1557291A (zh) 2004-01-14 2004-12-29 杨喜鸿 那格列奈分散片及其制备方法
WO2005094812A1 (ja) 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
JP2008265459A (ja) 2007-04-18 2008-11-06 Daihatsu Motor Co Ltd アクスルハウジング

Similar Documents

Publication Publication Date Title
JP2010047612A5 (enExample)
JP2011037832A5 (enExample)
NO20084992L (no) Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson&#39;s disease
JP2010132654A5 (enExample)
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
UA116334C2 (uk) Тверді форми дозування бендамустину
NO20083151L (no) Fast dispersjon omfattende en aktiv bestanddel med et lavt smeltepunkt, og tablett for oral administrering omfattende samme
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
JP2009537554A5 (enExample)
JP2010520246A5 (enExample)
MX2009011554A (es) Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
JP2014221827A5 (enExample)
JP2011506587A5 (enExample)
AR061790A1 (es) Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento
RU2014137096A (ru) Перорально вводимая фармацевтическая композиция
HRP20100120T1 (hr) Formulacije s valsartanom
RU2007107368A (ru) Композиция, содержащая десмопрессин
JP2018039810A5 (enExample)
MY153109A (en) A solid pharmaceutical formulation
JP2014218523A5 (enExample)
NO20090262L (no) Galeniske formuleringer av aliskiren og hydroklorotiazid
JP2015129124A5 (enExample)
JP2006342148A5 (enExample)
JP2013528213A5 (enExample)